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Abstract: In this short-review, the most common types of both pharmaceutical and personal care
products (PPCP, a class of “emerging pollutants”) are considered, as well as some of the most
frequent methods for their removal that envisage the use of nanomaterials. The nanomaterials
used in conservative methods (namely, reverse osmosis, nanofiltration and adsorption) are basically
nanoporous solids. Non-conservative methods, which include photocatalysis and Fenton reaction,
are currently considered more promising than conservative ones, as the former allow the (at least)
partial degradation of the original molecules into more biodegradable by-products, which can be
further abated by subsequent biological treatments, whereas the former are not efficient for the
removal of small quantities of pollutants and have to be regenerated.
Keywords: emerging pollutants; PPCPs; photocatalysis; nanomaterials
1. Introduction
Although pharmaceuticals and personal care products (PPCPs) have been used since the end of
the 19th century, only in the last two decades the concern for their (post disposal) persistence in the
environment has been raised, since they are bioactive species by showing either short or long term
toxicity [1–3].
Pharmaceutical products are drugs used to treat both human and animal illnesses, whereas
personal care products are mainly used in cosmetics [4]. After consumption and use, low concentrations
of PPCPs are continuously introduced in several ecosystems (soil, groundwater and fresh water)
through sewage and waste water treatment plants (WWTPs), and finally they are found in rivers and
in the surrounding environment [1,4,5].
Their very low concentration, ranging from a few ng L−1 to µg L−1, gives rise to a phenomenon
known as micro-pollution, which makes difficult their detection, analysis and degradation in
wastewater treatment plants [1]: usually, the latter are not designed and built to treat such low
concentrations, mainly due to a lack in both discharge guidelines and in environmental quality
standards [1,6].
Due to the availability of new (sensible and precise) analytic techniques, including liquid and
gas chromatography–mass spectroscopy [6,7], able to measure concentrations as small as nanograms,
it is now possible to detect and characterize such water micro-pollutants. The latter are also called
emerging contaminants (ECs), because data concerning their transport, fate, toxicity and tolerated
concentration in water bodies are not completely available [4].
ECs are essentially either naturally occurring or synthesized substances that interfere with the
functioning of endocrine systems and result in unnatural responses of the organisms. For such
compounds, regulations are still missing: ECs could be matter of future regulations, depending
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on the results of research concerning their potential effects on human health and the availability
of data on their occurrence in the environment. Some of these ECs do not need to be persistent
to be (potentially) harmful, since they are continuously introduced into the environment and so,
when degraded, are soon replaced.
ECs include not only PPCPs and steroid hormones, but also surfactants and pesticides [1].
Among these, PPCPs can easily dissolve in water, with high persistence due to their low volatility at
atmospheric temperature and pressure and low biodegradability.
Moreover, their effects differ from those of other contaminants, because drugs and their
metabolites are on purpose designed and synthesized to interact with cells. Therefore, when dispersed
in the environment, they can more easily react with non-target organisms [7]. Especially antimicrobials,
like antibiotics, are compounds that destroy or obstruct microbe proliferation.
Antibiotics are used to treat infectious diseases in human beings or animals and to preserve
food (under the American Food, Drug and Cosmetic Act) [8,9]. Recently, their use in husbandry has
been restricted, mainly in EU and USA, since their proliferation to prevent disease or spur growth
in livestock and aquaculture has created alarms for human resistance to microbes [10–12]. All this
notwithstanding, the production of antimicrobials is expected to increase up 67% by 2030, especially in
developing countries, including Brazil, Russia, India, China, and South Africa (Figure 1) [2,11,13].
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Figure 1. According to reference [2] *: Relative frequency of detection and median concentration of 
pharmaceuticals in receiving waters: (a) global; (b) Europe; (c) North America; and (d) Asia. (The 
circumference of each fan is scaled by the relative proportion of detections. Each point outward on 
the radial axis represents 10y of the median concentration in ng L−1. For example, the innermost circle 
represents 101 ng L−1; the second represents 102 ng L−1, etc.). * pubs.acs.org/doi/full/10.1021/es3030148, 
further permissions related to the material excerpted should be directed to the ACS. 
To date, several studies report the presence of pharmaceutical and endocrine disrupting 
compounds (EDCs) either in raw water for drinking use or in tap water for drinking use [2,14–19]. 
This review will firstly focus on the origin and fate of PPCPs (Table 1) and then on the methods 
envisaging the use of nanomaterials (NMs) to remove PPCPs from wastewater (Table 1). 
  
Figure 1. According to reference [2] *: Relative frequency of detection and median concentration
of pharmaceuticals in receiving waters: (a) global; (b) Europe; (c) North America; and
(d) Asia. (The circumference of each fan is scaled by the relative proportion of detections.
Each point outward on the radial axis represents 10y of the median concentration in ng L−1.
For example, the innermost circle represents 101 ng L−1; the second represents 102 ng L−1, etc.).
* pubs.acs.org/doi/full/10.1021/es3030148, further permissions related to the material excerpted
should be directed to the ACS.
To date, several studies report the presence of pharmaceutical and endocrine disrupting
compounds (EDCs) either in raw water for drinking use or in tap water for drinking use [2,14–19].
This review will firstly focus on the origin and fate of PPCPs (Table 1) and then on the methods
envisaging the use of nanomaterials (NMs) to remove PPCPs from wastewater (Table 1).
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Table 1. Pharmaceuticals and personal care products (PPCPs) and emerging contaminants (ECs)
commonly detected in water bodies.
Main Categories Families Examples
Drugs and
Pharmaceuticals
antibiotics/antibacterials amoxicillin, metronidazole, ofloxacin
steroids estrone, 17β-estradiol, testosterone
β-blocker propranolol, salbutamol, atenolol
nonsteroidal anti-inflammatory
drugs (NSAID) aspirin, ibuprofen, naproxen, ketoprofen
antiepileptic/anticonvulsants gabapentin, carbamazepine
antidepressant/hypnotic diazepam, venlafaxine, amitriptyline, dosulepin, meprobanate
analgesic morphine, propoxyphene, paracetamol
hypertension valsartan
lipid regulation bezafibrate, simvastatin, clofibric acid
erectile dysfunction sildenafil
Stimulant and generally
illegal drugs
hallucinogen
3,4-Methylenedioxymethamphetamine (MDMA),
3,4-Methylenedioxy-N-ethylamphetamine (MDEA),
3,4-Methylenedioxyamphetamine (MDA)
stimulant amphetamine, cocaine, benzylpiperazine
human indicator caffeine, nicotine
Personal care products
preservative methylparaben, propylparaben
sunscreen agent 1-benzophenone, homosalate
disinfectants/antiseptic chloramines, chlorine, chlorine dioxide,chlorhexidine digluconate
fragrances musk xylol, tonalide
Pesticides/Herbicides
organohalogenated compounds Dichlorodiphenyltrichloroethane (DDT), lindane,vinclozolin, clopyralid
nitrogen containing simazine, phenylurea
2. Source, Fate and Effects of Selected PPCs
The following PPCPs, which are recognized to be dangerous or considered possibly
dangerous to humans, animals and the environment will be considered here: antibiotics;
non-steroidal anti-inflammatory drugs; anti-hypertensives; anti-depressants; hormones and endocrine
disruptive compounds.
Antibiotics (ABs) found in the environment have an anthropogenic origin: they are usually related
to either human therapeutic usage (entering the environment through municipal wastewater) or
intensive animal agriculture usage [4].
So far, ABs are recognized to have potential effects on both human health and the environment.
The use in animal agriculture is indeed the major source of ABs, since they are used not only for
therapeutic purposes, but also for prevention and sub-therapeutic use to improve feed efficiency and
weight gain of the animals. Most of the ABs (ca. 90%) is indeed excreted back to the environment
by animals in a partially metabolized form, which depends on the parent AB. Some of the ABs,
like sulfonamides, are stable to degradation, in both biotic and abiotic conditions, and are found in
surface waters; sediments; municipal wastewaters; animal waste lagoons and underlying groundwater.
Some of the ABs used for animals are similar to those used for humans like, for instance, tylosin,
an AB used as a feed additive in animal agriculture, which has a human equivalent in erythromycin
(Figure 2). The issue concerning these two molecules is that if microbes become resistant to tylosin,
they could be resistant to erythromycin as well.
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an antibiotic used for human beings.
Non-steroidal anti-inflammatory drugs (NSAIDs, Table 1) are highly consumed drugs with
analgesic, antipyretic and anti-inflammatory effects: they are found in WWTPs (in concentrations up
to µg L−1) and in surface waters (in concentrations of ng L−1). Some of them, like aspirin, naproxen,
ibuprofen, etc. are also reported in drinking water [20].
Antihypertensive drugs are able to lower blood pressure by different means, and include
diuretics, angiotensin-converting-enzyme ACE inhibitors, calcium channel blockers, beta-blockers
and angiotensin II receptor antagonists. Usually, beta blockers (metoprolol, atenolol and propranolol),
are the most frequently reported drugs in surface water (in concentrations up to tens of ng L−1),
ground water, and sometimes drinking water.
Antidepressant drugs used for psycho-therapeutic use have been found in several types of
fish and, moreover, have showed to be able to alter their behavior (activity, boldness and sociality) [21].
Hormones and EDCs may have either natural or anthropogenic origin and could mimic or
interfere with body hormones. They can be found in both municipal waste water and waste water
coming from animal agriculture: both types of source are not equipped with plants able to remove
small amounts of these compounds, which are finally released to the environment. EDCs can for
instance have an impact on the reproductive system of fishes and may improve their vulnerability to
infectious diseases, causing an ultimate decline in fish population [22,23].
3. Removal of PPCPs by Conservative Methods Envisaging the Use of Nanomaterials
Non-reactive (conservative) methods imply the removal of the pollutant. The best results with
micro-pollutants like PPCPs are usually obtained with either membrane technology (i.e., by reverse
osmosis (RO) or nanofiltration (NF)) or adsorption [6]. RO is a method based of a semipermeable
membrane able to remove certain ions and particles from a liquid stream. NF is a similar treatment,
based on a membrane, but giving a coarser filtration without removing minerals, which are otherwise
removed during the RO process.
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RO and NF are particularly useful methods for the removal of micro-pollutants from drinking
water, though there is still some lack of knowledge about their actual performance, which is influenced
by several factors [6,24,25], such as the selectivity of organic and inorganic compound removal,
salt permeability, pressure and temperature, recovery and feed water concentration. RO membranes
are very energy intensive, but the occurrence of pore sizes in the 1.0–5.0 nm range may lead to more
than 90% separation of organic molecules from the liquid phase.
NF membranes have larger pores (5.0–10 nm range) with respect to RO membranes and show a
good performance only for big molecules, like pesticides, whereas they do not remove small molecules,
such as ions. Generally, the rejection efficiency (and thus the separation performance) of a membrane is
influenced both by mechanisms of size exclusion (molecular sieving) and type of sorption interactions
at the liquid–solid interface (van der Waals forces, dipole–dipole forces, etc.).
The sieving effect, with the related mass-transfer phenomena occurring during diffusion and
separation, controls the performance of RO membranes, whereas the type of sorption interaction
controls that of NF membranes.
A study concerning the removal of EDCs showed that RO membrane efficiency increases with the
molar mass of the target species if the latter are neutral molecules [26], whereas the efficiency of NF
membranes increases with the charge and the molar mass of ionic compounds [27]. During membrane
operation, some deposition phenomena at the membrane surface may occur that, in some cases,
may lead to an improved separation efficiency of the membrane, whereas in other cases may lead to
undesired fouling phenomena that have to be taken into account [26,28,29].
Polyamide NF/RO cationic membranes have been used for the rejection of 11 compounds
including both EDCs and other pharmaceutical active compounds (PhACs) [30]. Two types of
membranes were considered, namely a polyamide membrane and a cellulose acetate membrane.
The former exhibited a better performance in terms of rejection of the selected compounds, but retention
was only in the 57–91% range. It was found that the two most common ways adopted to evaluate the
membrane rejection properties (i.e., molecular weight cut-off and salt rejection) were not appropriate
to provide quantitative information for EDC/PhAC rejection by NF/RO membranes. As a whole,
molecular weight exclusion controlled the rejection in polyamide membrane, whereas polarity mostly
controlled rejection in cellulose acetate membrane.
As a conclusion [30], each present (and future) material adopted in NF/RO membranes will exhibit
different trends for the rejection of micro-pollutants depending on the physico-chemical properties of
the target compounds.
Activated carbons (ACs) and other adsorbents, including naturally occurring materials
(wood, keratin) are considered as NMs reference for the separation of organic pollutants. It is generally
acknowledged that sorption kinetics are controlled by mass-transfer phenomena at the liquid/solid
interface, with retention being controlled by the sorbent/sorbate properties [31]. Therefore, the type of
interaction (strong or weak van der Waals forces) and the hydrophilic/hydrophobic properties of the
adsorbent are two crucial factors.
EDCs sorption on such kinds of nanoporous solids depends on both the molecule size and
charge density [26,32,33]. The main drawbacks of this method, finally hampering an actual large-scale
application, are the competitive adsorption of other species present in water, like natural organic
matter (NOM, mainly constituted by humic and fulvic acids) and the fouling effect due to the presence
of xenobiotic compounds, such as surfactants, which lead to pore blockage and lower retention [34].
A clear example is given by a literature study reporting the sorption of 17β-estradiol onto granular
ACs that was reduced by three orders of magnitude in the presence of other organic compounds in
both natural waters and secondary treated wastewater [6].
Another issue related to adsorption method is the disposal of the adsorbent after its use, which is
complicated by the fact that the (initially) diluted organic pollutants have been transferred to the solid
from the liquid phase and have been finally concentrated in the adsorbent.
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For the above reasons, many efforts are currently underway to develop (efficient) non-conservative
methods, where the PPCPs are converted into less dangerous and more biodegradable by-products,
if not completely mineralized.
4. Removal of PPCPs by Non-Conservative Methods Envisaging the Use of Nanomaterials
4.1. Photocatalysis and Other Advanced Oxidation Processes
According to the literature, the non-conservative methods that are actually able to efficiently
remove PPCPs are mainly based on advanced oxidation processes (AOPs).
AOPs generally imply the in-situ production of highly reactive species (i.e., H2O2, OH·, O−, O3)
that allow the degradation of refractory organic pollutants into biodegradable compounds. Rather than
stand-alone methods, AOPs are really effective when used either before or after biological treatments.
AOPs may imply the use of nanomaterials (NMs) as either catalysts or photocatalysts,
which improve the selective removal of the target pollutant [35,36].
As far as PPCP removal by AOPs is concerned, mineralization of the PPCPs is not necessarily
achieved, with a consequent release into the environment of by-products that are indeed more
biodegradable (and less toxic) than the original drug. In those cases, a biological post-treatment
step may be feasible.
The most suitable AOPs for PPCP removal are heterogeneous photocatalysis, ozonation and
Fenton (or Fenton-like) reaction. While the first surely implies the use of NMs (like photocatalytic
nanoparticles or nanoporous materials), the other two may not.
A photocatalyst is a semiconductor where electrons are promoted from the valence band (VB)
to the conduction band (CB), after absorbing photons with higher energy than the semi-conductor
band gap energy (Figure 3). Photocatalysts can be activated by either simulated or natural light.
The generated holes (h+) can either oxidize adsorbed water molecules (or OH− ions) and produce OH
radicals or directly oxidize the adsorbed contaminants. The electrons transferred to the conduction
band can react either with oxygen (O2) dissolved in water (forming a superoxide radical ion O−2 ) or
directly with the contaminant at the surface. The reaction efficiency is driven by catalyst concentration,
pH, water composition, wavelength and intensity of radiation.
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by ZnO. The superior photocatalytic performance of P25 is mostly ascribed to the peculiar physico-
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sulfamethazine (an antibacterial agent) [38] and of the antibiotic chloramphenicol [39]. ZnO also 
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a chemical oxygen demand (COD) and a dissolved organic carbon (DOC) removal of 23.9% and 9.7% 
respectively [40]. ZnS nanoparticles were applied as a photocatalyst to remove some β-lactam 
antibiotics with a degradation yield of 82–100% in 2 h at pH 4.5 [41]. 
Figure 3. Sketch of a photocatalytic nanoparticle under illumination.
As a photocatalyst, TiO2 is inexpensive, non-toxic, photochemically stable and commercially
available in several crystalline forms and with different particle sizes and morphologies. Moreover,
by different methods, it is also possible to obtain TiO2 with a high surface area and relatively large
pores, allowing a facile reactant/product diffusion [37].
TiO2, and in particular Degussa P25 (hereafter referred to as P25) is universally considered
one of the most efficient photocatalysts for the abatement of several pollutants including PPCPs,
followed by ZnO. The superior photocatalytic performance of P25 is mostly ascribed to the peculiar
physico-chemical features of its crystallites, where the two crystalline phases anatase and rutile occur
in an 80:20 weight ratio [37]. The peculiar nanostructure of P25 favors the electron/hole separation,
lowering their recombination frequency.
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The behavior of ZnO was even more promising in the case of the photocatalytic abatement of
sulfamethazine (an antibacterial agent) [38] and of the antibiotic chloramphenicol [39]. ZnO also
showed good ability to completely degrade the ABs amoxicillin, ampicillin and cloxacillin in 3 h
with a chemical oxygen demand (COD) and a dissolved organic carbon (DOC) removal of 23.9% and
9.7% respectively [40]. ZnS nanoparticles were applied as a photocatalyst to remove some β-lactam
antibiotics with a degradation yield of 82–100% in 2 h at pH 4.5 [41].
As far as TiO2 water suspensions are concerned, some parameters like the pollutant concentration,
pH, light wavelength and intensity, the addition of other oxidants (like H2O2) and the type of water
matrix are crucial. In particular, pH influences the surface charge of TiO2, and thus organic pollutant
adsorption, a step that markedly influences their photocatalytic degradation. The surface charge is
related to the size of the particles. Generally, for P25 with a particle diameter ~25 nm, the pH at the
point of zero charge (pHPZC) is 6.9, which shifts to more basic values for smaller particles [42].
As adsorption of the target pollutants is a crucial step, the nature of the aqueous matrix is also
important, due to the simultaneous presence of other species like carbonates, humic acids or dissolved
gases, which may lead to competitive adsorption phenomena, lowering the final photocatalytic
efficiency. The degradation of amoxicillin, ampicillin and cloxacillin antibiotics in water solution
(Figure 4) under UV radiation (>300 nm) in presence of TiO2 was higher at pH 11, whereas complete
degradation was reached at pH 5 after addition of H2O2 [43].
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Different TiO2 nanomaterials may have different adsorption capacities towards different pollutants.
This has been clearly shown in a paper were the photocatalytic degradation (under simulated solar
irradiation) of both clofibric acid and carbamazepine (two pharmaceuticals with different therapeutic
effects) and of two contrast agents (iomeprol and iopromide) (Figure 5) was studied in aqueous
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suspensions containing either P25 or Hombikat UV100 [44], whose textural properties are reported in
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Table 2. General textural properties of TiO2-based photocatalysts. * particles size based on TEM images
and/or Scherrer calculation. Adapted from [44].
Characteristics P25 (TiO2) Hombikat UV100 Mesoporous Titania (TiO2)
r stallographic phase (w/w) 75 ± 5% anatase 25 ± 5% rutile 100% anatase 100% an t se
Diameter of particles (nm) * 15 ± 30 <10 <20
Specific surfac area (BET area, m2g−1) 60 ± 10 >250 150 ± 40
The results showed the better photocatalytic activity of P25 towards the degradation of clofibric
acid and carbamazepine. Hombikat UV100 was instead more effective towards the degradation
of iomeprol, likely due to a higher adsorption of the latter molecule at the surface of that solid.
Possible degradation products were also identified and quantified: with clofibric acid, several aromatic
and aliphatic degradation products were detected, and a possible multi-step degradation scheme was
proposed (Figure 6).
Moreover, a TiO2 photocatalyst-based process showed a good ability to remove up to 68%
chlorhexidine digluconate (CHD, an antiseptic compound), in 1 h at 25 ◦C with a substrate-to-catalyst
ratio of 2.5:1 under UV light at basic pH [45].
When micro-pollutants like PPCPs are concerned, the use of high surface area TiO2 may help their
adsorption. In this respect, mesoporous TiO2 can be obtained by different methods, including hard
and soft templates and sol–gel methods [37].
Some works report the photocatalytic performance of mesoporous TiO2 where the higher porosity
and higher specific surface area should play a prominent role: for instance, Zr-doped mesoporous TiO2
was tested for the degradation of ibuprofen and other (mainly anti-inflammatory) pharmaceuticals [46].
It was found that the material shows improved adsorption of the pollutants from the solution and high
initial photocatalytic activity. In the adopted experimental conditions, however, the rapid formation of
intermediates and of some polymeric compounds led to decreased activity in following cycles. pH was
found to deeply affect the photocatalytic activity, which increased by a factor of six when pH decreased
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from nine to two. According to the authors, the presence of surface Zr led to a more hydrophobic
material, with a higher affinity of non-polar molecules. Ibuprofen is a weak acid (pKa = 4.4) and at
low pH mostly occurs as undissociated molecules that can absorb at the surface by H-bond through
carboxylic groups. The (more hydrophilic) intermediates formed were instead desorbed.
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On the spur of the growing interest in the production of solar fuels, there is an increased interest
in developing solar photocatalysis also for the removal of pharmaceuticals, and several works report
on the use of (natural or simulated) solar radiation for the removal of pharmaceuticals. To this respect,
the photocatalytic degradation under sunlight of a common antibiotic (lincomycin) was studied in the
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presence of P25 [47]. A hybrid system (consisting of a solar photoreactor coupled with a membrane
module, used to confine both photocatalyst and pollutants in the reaction environment) was used as a
pilot plant (Figure 7). The antibiotic was successfully oxidized and the hybrid system resulted to be
particularly useful for that application.
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(F) manometer; (G) membrane vessel; (H) line under pressure; (I) rotameter; (L) feed tank; (PFP) plug
flow photoreactor. Reproduced with permission from [47], Copyright Elsevier Ltd., 2005.
The hybrid system allowed the simultaneous separation of the photocatalyst particles and of
lincomycin and its degradation products from the permeate flow; indeed, the membrane rejection for
those species was quite high. The analyses of the data collected by using the hybrid system, both in
total recycle and in continuous regime, indicated that the presence of the membrane allows reducing
the amount of both the substrate and intermediates to very low concentration levels.
This shows that the engineering of the photocatalytic system will play a prominent role in the
future, in ord r to allow an effective removal of such pollutants.
A hy ri UV/TiO2/O3 approach was adopted for the disposal of fluox tine [48] and norfluoxetine.
The former is the active principle of Prozac®, the latt r is its m in metabolite. B th ar non-biod gradable
and recalcitrant pharmaceutical products, which may be found in surface waters after therapeutic use.
Since current wastewater treatments are unable to remove them completely, a hybrid approach was
tested, with O3/H2O2 as oxidants and TiO2 as photocatalyst. In the same papers, other approaches
were also tested. In all the experiments, a strong pH dependence of the degradation of fluoxetine
was found. When Degussa P25 was adopted as a photocatalyst, the drug adsorption at the surface of
TiO2 NPs played an important role, in that the drug adsorption was enhanced at alkaline pH, whereas
mass transfer problems oc ur at acidic pH ( here both the drug a d th TiO2 surface are protonated).
A similar result was observed by some f us when the adsorption of negatively charged species on
meso orous TiO2 were studied [49,50].
From an economic point of view, however, any papers concluded that in the case of drugs,
homogeneous photocatalysis has a lower environmental impact as compared to heterogeneous processes.
To this respect, the degradation of α-methylphenylglycine, a common precursor of pharmaceuticals,
often chosen as an aromatic amino acid model molecule because of its high water solubility and its
non-biodegradable character, has been studied by means of solar photo-Fenton and TiO2 photocatalytic
degradation [51,52].
Solar photo-Fenton (combined with bi logical systems) is also adopted to treat wastewaters that
contain pharmaceuticals. In the paper, s lar photo-Fenton was more effecti e in the degradation, due to
a higher degradation rate. A photo-Fenton reaction at relatively low Fe concentration (20 mg L−1) was
able to degrade the parent compound completely and to convert the intermediates into biodegradable
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compounds in about one hour, without the need for removing Fe from water, as its concentration was
compatible with biologically-activated sludge treatment. H2O2 consumption is the main drawback of
photo-Fenton treatments, both because of its cost and because of the technical issues stemming from
the need to eliminate it before the water can be discharged to the biological treatment. However, it has
been demonstrated that by properly dosing H2O2, its consumption can be optimized in such a way as
to obviate the need for elimination after treatment.
Although photocatalysis can exploit natural solar light for contaminant degradation, its industrial
application struggles to be spread due to the dependence of radiation penetration on water depth
and the necessity to remove the catalyst at the end of the process. To skip the separation of the
nanomaterials from the aqueous medium, which can be an expensive and time consuming step,
semiconductors can be immobilized on a support [53]. The support can be either transparent
(e.g., glass, silica gel, etc.) or opaque (AC, metals, etc.) material with a strong adherence to the
catalyst, a high specific surface area, inertness with respect to the photocatalyst, but with a fair
adsorption affinity towards the contaminants [54]. For example, Murgolo et al. show a good
efficiency of nanometric TiO2 supported on single walled carbon nanotubes during the degradation of
a mixture of 22 PPCPs either in pure water or in secondary wastewater effluent [55]. Very recently,
Karaolia et al. have synthesized graphene-based TiO2 composite photocatalysts to remove antibiotics
and antibiotic-resistant bacteria, such as sulfamethoxazole, erythromycin and clarithromycin, in urban
wastewater. Their nanocomposite has shown to be efficient in the photocatalytic degradation of
erythromycin (ca. 84%) and clarithromycin (ca. 86%), while the degradation of sulfamethoxazole
(ca. 87%) was found to be marginally slower compared to P25 [56].
4.2. Reaction with Nanoscale Zero Valent Iron
In the last two decades, nanoscale zerovalent iron (NZVI) particles have been considered a
promising nanomaterial to remove a wide range of contaminants including heavy metals, pesticides
and chlorinated solvents from both groundwater and wastewater [57–59].
Usually, NZVI particles are formed by a metallic iron core covered by an iron
oxide/hydroxide shell. They are generally suspended in a colloidal dispersion and stabilized by
a biopolymer [60,61] or a surfactant and, thanks to the highly specific surface area, can degrade
contaminants faster than (commercial) millimetric Fe0. Several degradation pathways can occur at the
surface of the NZVI, which generally lead to the reduction of the contaminant and the consumption
and oxidation of the metallic core (Figure 8).
Very recently, NZVI and commercial iron powder were applied during sludge anaerobic digestion
for the removal of 19 different types of PPCPs. They showed good efficiency in the presence of
chlorinated PPCPs, whereas no significant improvement was reported for the other types of PPCPs [62].
Appl. Sci. 2018, 8, x FOR PEER REVIEW  11 of 16 
concentration was co patible with biologically-activated sludge treatment. H2O2 consumption is the 
main drawback of photo-Fe ton treatments, both because of its cost and because of the technical 
issues stemming from the need to eliminate it before the water can be discharged to the biological 
treatment. However, it has been demonstrated that by properly dosing H2O2, its consumption can be 
optimized in such a way as to obviate the need for elimination after treatment. 
Although photocatalysis can exploit natural solar light for contaminant degradation, its 
industrial application struggles to be spread due to the dependence of radiation penetration on water 
depth and the nec ssity to remove the catalyst a  the end of the process. To skip the separ tion of the 
nanomaterials from the aqueous medium, which can be an expensive and time consuming step, 
semiconductors can be immobilized on a support [53]. The support can be either transparent (e.g., 
glass, silica gel, etc.) or opaque (AC, metals, etc.) material with a strong adherence to the catalyst, a 
high specific surface area, inertness with respect to the photocatalyst, but with a fair adsorption 
affinity towards the contaminants [54]. For example, Murgolo et al. show a good efficiency of 
nanometric TiO2 supporte  on single walled carbon nanotubes during the degradation of a mixture 
of 22 PPCPs either in pu e water or in secondary wastewater effluent [55]. Very recently, Karaolia et 
al. have synthesized graphene-based TiO2 composite photocatalysts to remove antibiotics and 
antibiotic-resistant bacteria, such as sulfamethoxazole, erythromycin and clarithromycin, in urban 
wastewater. Their nanocomposite has shown to be efficient in the photocatalytic degradation of 
erythromycin (ca. 84%) and clarithromycin (ca. 86%), while the degradation of sulfamethoxazole (ca. 
87%) was found to be marginally slower compared to P25 [56]. 
4.2. Reaction with Nanoscale Zero Valent Iron 
In the last two decades, nanoscale zerovalent iron (NZVI) particles have been considered a 
promising nanomaterial to remove a wide range of contaminants including heavy metals, pesticides 
and chlorinated solvents from both groundwater and wastewater [57–59]. 
Usually, NZVI particles are formed by a metallic iron core covered by an iron oxide/hydroxide 
shell. They are generally suspended in a colloidal dispersion and stabilized by a biopolymer [60,61] 
or a surfactant and, thanks to the highly specific surface area, can degrade contaminants faster than 
(commercial) millimetric Fe0. Several degradation pathways can occur  the surface of the NZVI, 
which generally lead to the reduction of the contaminant and the consumption and oxidation of the 
metallic core (Figure 8). 
Very recently, NZVI and commercial iron powder were applied during sludge anaerobic 
digestion for the removal of 19 different types of PPCPs. They showed good efficiency in the presence 
of chlorinated PPCPs, whereas no significant improvement was reported for the other types of PPCPs 
[62]. 
 
Figure 8. Sketch of a core–shell iron based nanoparticle for water remediation. Figure 8. Sketch of a core–shell iron based nanoparticle for water remediation.
Appl. Sci. 2018, 8, 170 12 of 16
Even more recently, Cao et al. have shown that NZVI with a sulfur based shell, (S-NZVI) is able
to degrade florfenicol (FF), which is considered a target molecule for ABs. The removal efficiencies
were good in groundwater, river water, seawater, and wastewater [63]. In their interesting system,
the shell is formed by FexSy, which has a higher affinity with the hydrophobic part –Cl and –F group
on FF compared to the more hydrophilic iron oxides–hydroxides and also facilities electron transfer
due to a lower bandgap than FexOy.
5. Conclusions and Future Perspectives
Nowadays, it is not possible to think of using fresh water just once, since its scarcity is an
enormous environmental problem, both for municipal and agricultural use. Therefore, it is necessary
to re-use all kinds of wastewater, including industrial, sanitary and combined sewage wastewater.
To make this possible, however, it is necessary to make them completely free from contaminants and
environmentally compatible, as well.
Therefore, the legislation of each country should be updated to new, acceptable PPCP threshold values.
WWPTS should be upgraded to detect and remove the new PPCs from aquatic systems. In this scenario,
(photo)catalysts or nanoparticles coupled with a support or showing magnetic properties could be
easily removed from the water after the treatment and easier regenerated than normally-dispersed
colloidal nanoparticles with a possible higher efficiency than conservative methods. The application
of nanostructured catalysts can be an attractive method since their properties and selectivity can be
tuned according to the contaminants present in the wastewater stream (Table 3). Unfortunately, their
industrial application is still hindered by their costs and possible toxicological issues. These drawbacks
will be easily overcome with future toxicological studies and new synthesis methods. Conservative
methods based on nanostructured materials, such as activate carbons, RO and NF are currently
cheaper, but their selectivity in contaminant removal is their principal shortcoming. For example,
the RO method, along with removing harmful compounds, also removes vitamins and minerals from
the water that are essential for healthy drinking water.
Table 3. Summary of the nanostructured catalysts, particles and contaminants. The pH reported refers
to the optimum or initial conditions.
Catalyst SSA (m2·g−1) Contaminant Conditions at RoomTemperature Reference
Degussa P25
(commercial) - prozac
75 W High pressure Hg
lamp (max 360 nm) + O3
at pH 11
[47]
Degussa P25
(commercial) - α-methylphenylglycine UV at pH 6 [51]
TiO2 (commercial) -
amoxicillin,
ampicillin and
cloxacillin
UV (365 nm) at pH 11
and + H2O2 at pH 5
[42]
Degussa P25 + NF
membrane
(both commercial)
50 lyncomycin UV light at pH 6.3 [46]
TiO2 and Aeroxide
P25 (commercial) 45–55/35–65 chlorhexidine UV at pH 10.5 [44]
P25 and Hombikat
UV100
(both commercial)
Table 2
carbamazepine,
clofibric acid,
iomeprol,
iopromide
Solar Simulator at pH 6.5 [43]
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Table 3. Cont.
Catalyst SSA (m2·g−1) Contaminant Conditions at RoomTemperature Reference
TiO2, P25 and ZnO
(all commercial) - sulfamethazine
9 W lamp Osram Dulux
S (320–400 nm,
max 365 nm) at pH 4.8
[38]
TiO2, P25 and ZnO
(all commercial) - chloramphenicol
9 W lamp Osram Dulux
S (320–400 nm,
max 365 nm) at pH 5.1 +
H2O2
[39]
Zr-TiO2 100 ibuprofen 4UV-vis solarium lamp [45]
TiO2 on SWCNT
(commercial) - 22 different PPCPs
UV and solar
simulated light [54]
graphene based
TiO2
45–48
sulfamethoxazole,
erythromycin and
clarithromycin
1 kW Xenon lamp at
pH 5.2–6.2 [55]
ZnO (commercial) -
amoxicillin,
ampicillin and
cloxacillin
6 W UV lamp
(max 365 nm) at pH 11 [40]
ZnS - β-lactam 500 W halogen lamp(visible lamp) at pH 4.5 [41]
NZVI 23.3 19 different PPCPs In dark, at pH 7 [61]
S-NZVI 62.5 florfenicol In dark, at pH 7 [62]
From another point of view, methods based on green chemistry or environmentally sustainable
chemistry should be implemented in order to reduce the spread of hazardous materials either by the
pharmaceutical industry to produce pharmaceutical compounds that are environmentally friendly or
by chemistry industry to develop new nanomaterials to remove contaminants.
We are aware that some nanomaterials, (e.g., TiO2 nanoparticles), used in this type of method,
could be per se considered as new emerging contaminants: to avoid this, they must be applied with
caution, so that they can become a useful tool for the efficient removal of contaminants. To do this,
however, there is room for a lot of scientific studies assessing the actual impact of such nanomaterials
in order to evaluate the advantages and disadvantages of their use in environmental remediation
processes, as well as there is still a lack of regulation that the different countries will soon have to face.
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